Characteristics of children surviving to 5 years of age or older with vertically acquired HIV infection

被引:0
|
作者
Kline, MW
Paul, ME
Bohannon, B
Kozinetz, CA
Shearer, WT
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objective of this study was to examine characteristics of long-term survivors (aged 5 years or older) of vertical human immunodeficiency virus (HIV) infection. A retrospective cohort study design was employed. Forty-eight (68%) of 71 children who were born before 1990 and evaluated in our center survived to at least 5 years of age; 41 (58%) children remain alive (median age, 7.3 years). Only one (11%) of nine children with initial acquired immunodeficiency syndrome (AIDS)-defining conditions in the first year of life survived to age 5, whereas 47 (76%) of 62 children who did not have AIDS by age 1 year were alive at 5 years of age (p = .0003). Seventeen (43%) of 40 children with AIDS-defining conditions before age 5, and all 31 children without such conditions, survived to age 5 years (p = .000001). All eight children with lymphoid interstitial pneumonitis/pulmonary lymphoid hyperplasia (LIP/PLH) as their sole AIDS-defining condition survived to age 5. All 24 children who had neither an AIDS-defining condition nor severe immunosuppression by 5 years of age, and 24 (51%) of 47 children who had either or both of these findings, survived to age 5 years (p = .00008). To date, only 16 (39%) of 41 surviving children older than 5 years of age have had an AIDS-defining condition. However, true nonprogression of HIV disease (no clinical signs or symptoms; no evidence of immunosuppression) was unusual, occurring in only two (5%) of the same 41 children. In our center, most children with vertical HIV infection survive to at least 5 years of age, but the prognosis is not as good for those who experience an AIDS-defining condition or severe immunosuppression in the first 5 years of life.
引用
收藏
页码:350 / 353
页数:4
相关论文
共 50 条
  • [1] Older children and adolescents surviving with vertically acquired HIV infection
    Thorne, C
    Newell, ML
    Botet, FA
    Bohlin, AB
    Ferrazin, A
    Giaquinto, C
    Gomez, ID
    Mok, JYQ
    Mur, A
    Peltier, A
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (04) : 396 - 401
  • [2] A Ukraine birth cohort of children with vertically acquired HIV infection
    Saboura Mahdavi
    Claire Thorne
    Ruslan Malyuta
    Igor Semenenko
    Tatyana Pilipenko
    Retrovirology, 6 (Suppl 1)
  • [3] Identifying and testing children at risk of vertically acquired HIV infection
    Sim, R.
    Broughton, C.
    Howard, L.
    Andrews, S.
    HIV MEDICINE, 2013, 14 : 33 - 33
  • [4] Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection
    Williams, AJ
    Duong, T
    McNally, LM
    Tookey, PA
    Masters, J
    Miller, R
    Lyall, EGH
    Gibb, DM
    AIDS, 2001, 15 (03) : 335 - 339
  • [5] A review of the psychological effects of vertically acquired HIV infection in infants and children
    Campbell, T
    BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 1997, 2 : 1 - 13
  • [6] Neuropsychological effects of vertically acquired HIV infection in children: A longitudinal perspective
    Becker, L
    New, M
    PEDIATRIC RESEARCH, 2002, 51 (04) : 27A - 27A
  • [7] Coming of age with HIV: A comparison of adolescents with sexually and vertically acquired infection.
    Freedman, JE
    Woods, ER
    Cavallo, MA
    Samples, CL
    JOURNAL OF ADOLESCENT HEALTH, 2000, 26 (02) : 108 - 108
  • [8] CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: Is it associated with age at initiation?
    Newell, ML
    Patel, D
    Goetghebuer, T
    Thorne, C
    Giaquinto, C
    Rampon, O
    D'Elia, R
    De Rossi, A
    Grosch-Worner, I
    Mok, J
    Bates, I
    de Jose, I
    Hawkins, F
    Garcia-Rodriguez, MC
    de Guevara, CL
    Pena, JM
    Garcia, JG
    Lopez, JRA
    Asensi-Botet, F
    Otero, MC
    Perez-Tamarit, D
    Orti, A
    San Miguel, MJ
    Scherpbier, H
    Kreyenbroek, M
    Godfried, M
    Nellen, FJB
    Boer, K
    Bohlin, AB
    Belfrage, E
    Naver, L
    Levy, J
    Hainaut, M
    Peltier, A
    Barlow, P
    Ferrazin, A
    De Maria, A
    Gotta, C
    Mur, A
    Lopez-Vilchez, MA
    Paya, A
    Carreras, R
    Valerius, NH
    Niemiec, T
    Marczynska, M
    JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (07): : 954 - 962
  • [9] Cholangiocarcinoma presenting in an adolescent with vertically acquired HIV infection
    Mangeya, N.
    Mafukidze, A. T.
    Pascoe, M.
    Mbuwayesango, B.
    Madziva, D.
    Ndlovu, N.
    Corbett, E. L.
    Miller, R. F.
    Ferrand, R. A.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2008, 19 (10) : 717 - 718
  • [10] Severe airflow obstruction in vertically acquired HIV infection
    Calligaro, Gregory L.
    Esmail, Aliasgar
    Gray, Diane M.
    RESPIROLOGY CASE REPORTS, 2014, 2 (04): : 135 - 137